Healthy Extracts Reports Fourth Quarter and Full Year 2021 Results
Healthy Extracts Inc. (OTCQB: HYEX) reported strong fourth quarter and full year results for 2021, showcasing a net revenue of $672,000 in Q4, up 77% sequentially and 394% year-over-year. The company reversed its previous net loss, achieving a net income of $535,000. Annual revenue increased 15% to a record $1.5 million, with gross profit at $695,000, representing 47.4% of net revenue. Healthy Extracts launched innovative nutraceuticals, including Ultimate Brain Nutrients™, and engaged brand influencer Whitney Johns to boost market presence.
- Net income improved to $535,000 in Q4 from a loss of $1.6 million YOY.
- Q4 net revenue reached $672,000, a 77% sequential and 394% YOY increase.
- Record annual revenue of $1.5 million, growing 15% from 2020.
- Gross profit of $695,000 was 47.4% of net revenue.
- Reduced operating expenses by $471,000 to $2.6 million in 2021.
- Net loss totaled $2.0 million for the full year 2021, though improved from $2.6 million in 2020.
- Operating expenses increased 85% to $712,000 in Q4 compared to the prior year.
LAS VEGAS, April 01, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, reported results for the fourth quarter and full year ended December 31, 2021.
Q4 Financial Highlights
- Net revenue totaled
$672,000 , up77% sequentially and up394% from the same year-ago quarter. - Net income of
$535,000 , improving from a net loss of$1.6 million in the same year-ago quarter.
Full Year 2021 Financial Highlights
- Net revenue increased
15% to record$1.5 million . - Gross profit was
$695,000 or47.4% of net revenue. - Operating expenses reduced by
$471,000 t o$2.6 million .
2021 Operational Highlights
- Introduced breakthrough nutraceutical formulation, Ultimate Brain Nutrients™ (UBN™) ACTIVATE™, clinically shown to increase key brain activity by as much as
46% . Clinical study highlighting the product’s benefits was published in Annals of Reviews and Research. - Introduced Ultimate Brain Nutrients RELIEF™ for migraine sufferers, a breakthrough natural treatment clinically shown to reduce symptom duration by
61% and frequency by39% . - Launched innovative brand influencer program that offers private label products and custom formulations for brand influencers.
- Engaged Whitney Johns, an accomplished fitness athlete, model, personal trainer and nutrition advocate, as the company’s first major influencer under the new brand influencer program.
- Unveiled new exclusive line of Whitney Johns natural health and fitness formulations.
- Introduced on-the-go gel packs with Healthy Extracts’ Citrus Bergamot and UBN ingredients under new exclusive U.S. and Canada licensing and manufacturing agreement with Gelteq.
- Secured two-year extension to exclusively offer Citrus Bergamot SuperFruit™ in the U.S. and Canada.
Management Commentary
“Our record performance in 2021 was driven by the strong ramp up in sales through both our wholesale distribution and direct-to-consumer channels, which includes subscription options,” commented Duke Pitts, president of Healthy Extracts. “These results also reflect our rapidly expanding customer base, with estimated customer lifetime value or CLV now exceeding
“The growth was also supported by the continued expansion of our portfolio of natural products for heart and brain health. This included the mid-year launch of UBN ACTIVATE, representing our entrance into the multi-billion dollar brain health supplements market. Then in the fourth quarter, we introduced UBN RELIEF, which is specially formulated to reduce the symptoms associated with migraine headaches. In fact, we recently reported clinical study results that demonstrate UBN RELIEF naturally alleviates migraine symptoms. We believe such peer-reviewed, published clinical research highly differentiates our products in the marketplace and assures our customers they will see results. Like with ACTIVATE, we believe RELIEF is like no other product available today, and we see these products creating a tremendous market opportunity that supports the continued ramp up in sales over the months to come.
“One of the most exciting events of 2021 was the introduction of our exclusive line of Whitney Johns natural health and fitness formulations. Backed by Whitney’s tremendous personal endorsement and brand marketing strength, we see this new line dramatically elevating our social engagement, strengthening our brand identity, and especially accelerating our revenue growth at minimal cost. We believe major brand influencers like Whitney will help our formulations reach millions of new consumers and enable us to secure prime shelf placements at major retailers nationwide.
“While we were able to grow our direct sales business at a fast pace in 2021, we saw reduced sales in our wholesale business due to the COVID-19 pandemic. This turned around at the beginning of this year with a large follow-on purchase order for our exclusive Citrus Bergamot SuperFruit™ from XYMOGEN®, a major distributor to healthcare practitioners of clinical-grade nutraceuticals. This and similar follow-on wholesale orders demonstrates the growth of our B2B distribution segment is back on track for this year.
“To support the further growth across all of our segments, we recently appointed Scott Landers as EVP of sales and marketing. He brings to us more than 20 years of exceptional executive experience and accomplishment, including the successful launch of new products and services for KPMG, IBM, DISH Network, CenturyLink, NEC and other industry leaders.
“To add further fuel to our growth in 2022, we have in the works a number of new clinically-backed formulations for additional health offerings like hormone support and gut health. Combined with our expanding sales channels, including Amazon, where we have become a very active seller, we believe we are well on course for at least a doubling of our organic revenue growth in 2022. This excludes the potential positive impact of our active M&A program.
“We also expect to realize certain advantages from our supply chain management and significant post-acquisition overhead reductions we implemented last year, which we see supporting a transition to cash flow positive in the second half of this year.”
Q4 Financial Summary
Net revenue in the fourth quarter of 2021 increased
Gross profit totaled
Operating expenses increased
Net income totaled
Cash totaled
Full Year 2021 Financial Summary
Net revenue in the full year 2021 increased
Gross profit was
Operating expenses decreased
Net loss totaled
About Healthy Extracts “Live Life Young Again”
Healthy Extracts Inc. is a platform for developing or acquiring science-forward, clinically proven, plant-based proprietary products in select high-growth categories within the multibillion-dollar nutraceuticals market.
The company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with healthy heart benefits backed by more than 17 clinical studies.
UBN KETONOMICS® proprietary formulations have been clinically shown to improve brain health, including memory, cognition, focus and neuro-energy. UBN is pursuing intellectual property license opportunities for monetizing its IP portfolio of multiple issued and pending patents.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on February 19, 2021, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food and Drug Administration Disclosure
The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™
Healthy Extracts Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor Contact:
Ronald Both or Justin Lumley
CMA
Tel (949) 432-7566
Email contact
Media Contact:
Tim Randall
CMA
Tel (949) 432-7572
HEALTHY EXTRACTS, INC.
CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE 3 MONTHS ENDED | FOR THE 12 MONTHS ENDED | ||||||||||||||
DECEMBER 31, | DECEMBER 31, | ||||||||||||||
2021 (Unaudited) | 2020 (Unaudited) | 2021 (Audited) | 2020 (Audited) | ||||||||||||
REVENUE | |||||||||||||||
Gross revenue | $ | 766,372 | $ | 142,399 | $ | 1,676,598 | $ | 1,299,398 | |||||||
Less selling fees | (94,783 | ) | (6,497 | ) | (210,816 | ) | (22,839 | ) | |||||||
Net revenue | 671,589 | 135,902 | 1,465,782 | 1,276,559 | |||||||||||
COST OF REVENUE | |||||||||||||||
Cost of goods sold | 199,481 | 29,459 | 346,156 | 465,010 | |||||||||||
Written off inventory | 423,767 | 1,382,364 | 424,548 | 1,389,991 | |||||||||||
Total cost of revenue | 623,248 | 1,411,823 | 770,704 | 1,855,001 | |||||||||||
GROSS PROFIT | 48,341 | (1,275,921 | ) | 695,078 | (578,442 | ) | |||||||||
OPERATING EXPENSES | |||||||||||||||
General and administrative | 711,897 | 385,701 | 2,584,256 | 1,474,891 | |||||||||||
Impairment of assets | - | - | - | 1,579,883 | |||||||||||
Total operating expenses | 711,897 | 385,701 | 2,584,256 | 3,054,774 | |||||||||||
OTHER INCOME (EXPENSE) | |||||||||||||||
Interest expense, net of interest income | (3,855 | ) | (655 | ) | (52,453 | ) | (72,882 | ) | |||||||
Change in fair value on derivative | 1,202,646 | 3,077 | (85,325 | ) | 1,053,186 | ||||||||||
Loss on extinguishment of debt | - | - | - | 46,836 | |||||||||||
SBA loan forgiveness | - | 29,700 | 39,833 | 29,700 | |||||||||||
Gain on sale of asset | - | - | - | - | |||||||||||
Total other income (expense) | 1,198,791 | 32,122 | (97,945 | ) | 1,056,841 | ||||||||||
Net gain/(loss) before income tax provision | 535,235 | (1,629,500 | ) | (1,987,122 | ) | (2,576,375 | ) | ||||||||
NET GAIN/(LOSS) | $ | 535,235 | $ | (1,629,500 | ) | $ | (1,987,122 | ) | $ | (2,576,375 | ) | ||||
Loss per share - basic and diluted | $ | 0.00 | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
Weighted average number of shares outstanding - basic and diluted | 319,209,932 | 237,300,091 | 319,209,932 | 237,300,091 | |||||||||||
HEALTHY EXTRACTS, INC.
CONSOLIDATED BALANCE SHEETS
(Audited)
DECEMBER 31, | DECEMBER 31, | ||||||
2021 | 2020 | ||||||
ASSETS | |||||||
CURRENT ASSETS | |||||||
Cash | $ | 222,098 | $ | 59,201 | |||
Accounts receivable | 133,340 | 13,274 | |||||
Inventory | 1,957,966 | 2,417,683 | |||||
Total current assets | 2,313,404 | 2,490,158 | |||||
Fixed assets, net of accumulated depreciation of | 1,035 | 6,135 | |||||
Patents/Trademarks | 521,881 | 425,877 | |||||
Goodwill | 193,260 | 193,260 | |||||
Total other assets | 716,175 | 625,272 | |||||
TOTAL ASSETS | $ | 3,029,579 | $ | 3,115,430 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
LIABILITIES | |||||||
Accounts payable | $ | 37,267 | $ | 64,836 | |||
Accrued liabilities | 59,264 | 9,054 | |||||
Notes payable | - | - | |||||
Notes payable - related party | 170,866 | 170,866 | |||||
Convertible debt, net of discount of | 171,750 | 6,750 | |||||
Convertible debt - related party, net of discount of | - | - | |||||
Accrued interest payable | 13,050 | 2,379 | |||||
Accrued interest payable - related party | 14,118 | 518 | |||||
Derivative liabilities | 92,527 | 7,202 | |||||
Total current and total liabilities | 558,841 | 261,604 | |||||
STOCKHOLDERS' EQUITY (DEFICIT) | |||||||
Preferred stock, | - | - | |||||
Common stock, | 338,384 | 308,887 | |||||
Additional paid-in capital | 17,075,974 | 15,501,436 | |||||
Accumulated deficit | (14,943,620 | ) | (12,956,498 | ) | |||
Total stockholders' equity (deficit) | 2,470,738 | 2,853,826 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | $ | 3,029,579 | $ | 3,115,430 |
FAQ
What were Healthy Extracts Inc.'s fourth quarter results for 2021?
How did Healthy Extracts perform financially in 2021?
What new products did Healthy Extracts launch in 2021?
What is the stock symbol for Healthy Extracts?